関連する実験動画
Updated: Jul 18, 2026

14:06
Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
Published on: April 16, 2013
推定早期発症のB型 estreptococcal新生児疾患である
Suzanne Luck1, Michael Torny, Katrina d'Agapeyeff
1St George's Hospital, London, UK.
Lancet (London, England)
|June 13, 2003
まとめ
早期発症集団B型ストレプトコッカ菌 (EOGBS) 感染症は,培養で証明された症例だけで過小評価されています. 可能性のあるEOGBS症例を含むことは,より高い疾患負担を明らかにし,予防戦略をサポートします.
科学分野:
- 新生児医学 新生児医学
- 感染症 感染症は感染症です.
- 微生物学 微生物学とは
背景:
- 早期発症グループB型ストレプトコッカル (EOGBS) 感染症の発生率の推定は,しばしば培養で証明された症例に依存します.
- 文化で証明された方法は,偽ネガティブな結果のために,EOGBSの真の負担を過小評価することがあります.
- EOGBS感染の可能性は,グループBの estreptococciのコロニー化と臨床性セプシス徴候によって定義されます.
研究 の 目的:
- 新生児における確固たるEOGBS感染と確定的EOGBS感染の合計発生率を決定する.
- 伝統的な方法によるEOGBS疾患負担の過小評価を強調する.
- EOGBS予防戦略の必要性を裏付ける証拠を提供すること.
主な方法:
- イギリスにおける1年間の予測データ収集.
- 生後72時間以内にセプティックスクリーンを必要とする新生児を含む.
- EOGBS感染の確証と確証の合計発生率の計算.
主要な成果:
- EOGBSの確固たる感染と確定的感染の発生率は,生児1000人当たり3.6であった.
- この割合は,以前,培養で証明されたセプシスの数値だけで示唆されていたよりも著しく高い疾患負担を示しています.
- この発見は,培養で証明されたデータだけに頼るという限界を強調している.
結論:
- 早期発症したグループBの estreptococcal感染の真の負担は,培養で証明された症例によって示されるよりも大きい.
- EOGBS感染の可能性の定義は,より正確な病気の評価のために非常に重要です.
- これらの発見は,英国におけるEOGBS予防戦略の実施と強化を支援しています.
関連する概念動画
Probability Laws
Overview
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

